Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.
D000293:Adolescent; D000328:Adult; D000613:Aminobutyrates / Q000031:analogs & derivatives*; D000818:Animals; D002722:Chlorobenzenes / Q000494:pharmacology / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003655:Decerebrate State; D003975:Diazepam / Q000494:pharmacology; D004341:Drug Evaluation; D004569:Electroencephalography; D006801:Humans; D007408:Intestinal Absorption; D008875:Middle Aged; D009046:Motor Neurons / Q000187:drug effects; D009103:Multiple Sclerosis / Q000188:drug therapy; D009135:Muscular Diseases / Q000188:drug therapy*; D010919:Placebos; D012023:Reflex, Monosynaptic / Q000187:drug effects; D012026:Reflex, Stretch / Q000187:drug effects; D012216:Rheumatic Diseases / Q000188:drug therapy; D013122:Spinal Diseases / Q000188:drug therapy; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000506:poisoning / Q000627:therapeutic use
D000613:Aminobutyrates; D002722:Chlorobenzenes; D010919:Placebos; D005680:gamma-Aminobutyric Acid; D003975:Diazepam